Global Electrophoresis Market Report to 2029 - Featuring Thermo Fisher Scientific, Bio-Rad Laboratories, GE Healthcare and Helena Laboratories Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 15, 2022--
The “Electrophoresis Market Analysis by Product, by Application by End user, and by Region - Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The electrophoresis market size is estimated to be USD 3.1 billion in 2021 and is expected to witness a CAGR of 7.23% during the forecast period 2022-2029.
- Thermo Fisher Scientific Inc. (US)
- Bio-Rad Laboratories Inc. (US)
- Merck Group (Germany)
- Agilent Technologies Inc. (US)
- Danaher Corporation (US)
- GE Healthcare (US)
- PerkinElmer Inc. (US)
- QIAGEN N.V. (Netherlands)
- Harvard Bioscience Inc. (US)
- Shimadzu Corporation (Japan)
- Lonza Group Ltd. (Switzerland)
- Sebia Group (UK)
- C.B.S. Scientific Company Inc.(US)
- Helena Laboratories (US)
- Takara Bio Inc. (Japan)
- Teledyne Technologies (US)
- VWR International (US)
- TBG Diagnostic Ltd. (Australia)
The increased use of capillary electrophoresis with mass spectrometry, the rising use of next-generation sequencing, and the growing number of clinical, forensic, and research laboratories factors contributing to the market growth. However, presence of alternative is expected to hinder the growth.
Based on product, the market is segregated into electrophoresis software, gel documentation systems, electrophoresis systems, and electrophoresis reagents. In 2021, the electrophoresis reagents segment accounted for the highest revenue share owing to the growing need for 2D electrophoresis for protein separation in a variety of applications such as drug development, protein mapping, and chronic illness diagnostics, along with the expanding application fields of capillary electrophoresis.
However, the rising utilization of consumables in the areas of drug discovery, personalized medicine, genomics, antibody creation proteomics, and, others are also helping the market growth.
On the basis of application, the market is categorized into diagnostics, research, and quality control & process validation. In 2021, the research segment accounted for the highest revenue share due to the increasing popularity of electrophoresis equipment and consumables, rising in the field of biomarker discovery and NGS, and the rising use of electrophoresis in drug development, proteomics, genomics, and antibody studies.
By End user
Based on end user, pharmaceutical & biotechnology companies, academic & research institutes, hospitals, and other end users. In 2021, the academic & research institutes segment accounted for the highest revenue share owing to the demand for electrophoresis goods rising as a result of the expanding research being done in the disciplines of proteomics, sequencing, personalized medicine, and drug design, biomarker, genomics, and identification. However, the rising industry-academia alliances and research grants for genomes and proteomics research among academic and research institutes also support the market growth.
In 2021, North America region accounted for the highest revenue in the electrophoresis market and is expected to maintain its dominance during the forecast period. This is attributed to the increased proteomics and genomics research, rising investments by pharmaceutical and biotechnology companies, increased awareness of personalised therapeutics, and increased research activities in the field of mAb-based therapeutics.
For more information about this report visit https://www.researchandmarkets.com/r/cpin3q
View source version on businesswire.com:https://www.businesswire.com/news/home/20221215005733/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: OTHER SCIENCE SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/15/2022 10:25 AM/DISC: 12/15/2022 10:25 AM